Simvastatin Re-Sensitizes Hepatocellular Carcinoma Cells to Sorafenib by Inhibiting HIF-1α/PPAR-γ/PKM2-mediated Glycolysis

Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-020-1528-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

MicroRNA-1468 Promotes Tumor Progression by Activating PPAR-γ-mediated AKT Signaling in Human Hepatocellular Carcinoma

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2018English

Cytotoxicity of Sorafenib in Human Hepatocellular Carcinoma Cells

Al-Azhar Journal of Pharmaceutical Sciences
2015English

Dandelion Polysaccharide Exerts Anti-Angiogenesis Effect on Hepatocellular Carcinoma by Regulating VEGF/HIF-1α Expression

Frontiers in Pharmacology
Pharmacology
2020English

111 Systemic Chemotherapy Promotes HIF-1α Mediated Glycolysis and IL-17F Pathways in Mycosis Fungoides

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Downregulation of DcR3 Sensitizes Hepatocellular Carcinoma Cells to TRAIL-induced Apoptosis

OncoTargets and Therapy
OncologyPharmacology
2017English

PDCD2 Sensitizes HepG2 Cells to Sorafenib by Suppressing Epithelial‑mesenchymal Transition

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Effect of Sorafenib on Des‑γ‑carboxyprothrombin Secretion by a Human Hepatocellular Carcinoma Cell Line

Oncology Letters
Cancer ResearchOncology
2017English

Bufalin Sensitizes Human Bladder Carcinoma Cells to TRAIL-mediated Apoptosis

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy